This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

6 Health-Care Stocks for 2011: Fund Managers

Zagunis thinks demographic trends should support Stryker (SYK - Get Report), a knee- and hip-implant specialist, as the American population gets older. "The addition with Stryker is that they have a remarkably strong balance sheet with over $10 in cash per share on their balance sheet and no debt. They also have expansion plans that support performance in the next several years."

Liss agrees with the "aging of America" argument, but prefers Zimmer (ZMH) to Stryker.

"They are both good companies, but we are more disposed to Zimmer because they are more of the pure play on orthopedics," Liss says. "They have 75% of their business coming from hips and knees. They have a very good balance sheet and a good market-share position. And we think they are going to benefit from the new health-care law as more people gain eligibility and can utilize those products."

As for the specter of so-called "ObamaCare" that weighed on the sector throughout 2010, Liss believes UnitedHealth Group (UNH - Get Report) could actually stand to benefit as the new legislation takes effect.

"It's actually going to be pretty good for UnitedHealth coming out of this because they are going to have a lot of opportunity to get new lives under their care," Liss says. "We are talking about 30 million people who will most likely be insured going out to 2019. It will start to pick up in 2014 when the major provisions of the health-care law kick in."

He adds, "They have a great market-share position in Medicare Advantage, and the cuts there have been overblown. They have been able to manage through that pretty well."

>>To see these stocks in action, visit the 6 Health-Care Stocks for 2011 portfolio on Stockpickr.

Readers Also Like:




Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
JNJ $99.81 0.80%
MDT $77.51 0.05%
PFE $35.80 1.30%
ZMH $106.50 0.68%
UNH $121.22 -0.25%

Markets

Chart of I:DJI
DOW 17,733.65 +103.38 0.59%
S&P 500 2,106.18 +12.93 0.62%
NASDAQ 5,100.5090 +11.3030 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs